Diagnosing type 1 diabetes
Last reviewed November 17, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.
The blood tests that diagnose diabetes are the same for both types. The tests that tell them apart are different, and in adults they are frequently not done.
Unlike type 2, a new diagnosis of type 1 is usually urgent. Someone losing weight with heavy thirst needs to be seen the same day, not booked for next week.
Related pages: Type 1 diabetes
The bottom line
- Diabetes is diagnosed by glucose or A1C, the same thresholds for both types.
- Islet autoantibodies confirm the autoimmune cause.
- A low or undetectable C-peptide shows the body is not making insulin.
- Ketones should be checked at presentation.
- New symptoms with weight loss need same-day assessment.
- How often adult type 1 is initially misclassified.
- Whether C-peptide should be measured routinely in all new diabetes.
- How to reduce ketoacidosis at first presentation.
The story, step by step
What the evidence labels mean
Same thresholds as any diabetes
What happens
Glucose or A1C.
What the research shows
- A random plasma glucose of 200 mg/dL or higher with classic symptoms is diagnostic.
- A fasting plasma glucose of 126 mg/dL or higher, or an A1C of 6.5 percent or higher, also qualifies.
- In a symptomatic person with a clearly raised glucose, treatment starts immediately rather than waiting for confirmation.
- A1C can underestimate the situation in rapid-onset type 1, because glucose may have been high for only a few weeks. A normal or borderline A1C does not exclude it.
- Ketones should be checked at presentation, in blood or urine, because their presence changes the urgency entirely.
- Blood is also checked for electrolytes, kidney function and acid-base status if there is any suspicion of ketoacidosis.
Why it matters
Waiting for a confirmatory test in a symptomatic, thin, rapidly deteriorating person is how people arrive in intensive care. The urgency is the point.
What's still uncertain
- Whether A1C should be used at all in suspected type 1.
- How best to triage new diabetes in primary care.
Read more
- NIDDK: Type 1 diabetesGovernment
- MedlinePlus: Type 1 diabetesGovernment
- American Diabetes Association: standards of care resourcesNonprofit
Next: Which type
Antibodies and C-peptide
What happens
The two tests that settle it.
What the research shows
- Islet autoantibodies, GAD65, IA-2, insulin autoantibodies and ZnT8, confirm an autoimmune cause. Most people with type 1 have at least one.
- C-peptide is produced in equal amounts to the body's own insulin and is not present in injected insulin, so it measures native production specifically.
- In type 1, C-peptide is low or undetectable. In type 2 it is normal or high.
- C-peptide should be interpreted alongside a simultaneous glucose, because a low value when glucose is also low means little.
- Insulin autoantibodies become uninformative once insulin treatment starts, so testing early matters.
- A small share of people with clinical type 1 are antibody-negative, and C-peptide becomes the more useful test in that situation.
Why it matters
These two tests cost very little and resolve a question that otherwise gets answered by watching someone fail on tablets for a year.
What's still uncertain
- Whether all newly diagnosed adults should receive antibody testing.
- The best C-peptide thresholds for classification.
Read more
- American Diabetes Association: standards of care resourcesNonprofit
- NIDDK: Type 1 diabetesGovernment
- MedlinePlus: Blood glucoseGovernment
Next: In adults
Where it goes wrong
What happens
Assumed to be type 2.
What the research shows
- Roughly half of new type 1 diagnoses are in adults, and adults presenting with diabetes are usually assumed to have type 2.
- Features that should prompt a rethink: normal or low body weight, rapid onset, marked weight loss, ketones, another autoimmune condition, a poor response to tablets, or a family history of autoimmunity.
- Latent autoimmune diabetes in adults, LADA, progresses slowly, so tablets appear to work for months or years before failing.
- Misdiagnosis delays insulin, and in some cases the first correction comes via an admission with ketoacidosis.
- Being overweight does not exclude type 1. Rates of overweight in the population mean many people with type 1 are not thin.
- If the diagnosis does not behave as expected, the right question is whether the classification was right, not whether to add another tablet.
Why it matters
This is the most consequential diagnostic error in diabetes care, and the test that would prevent it is a single blood sample.
What's still uncertain
- How long misdiagnosis typically persists.
- Which clinical features discriminate best in practice.
Read more
- American Diabetes Association: standards of care resourcesNonprofit
- NIDDK: Type 1 diabetesGovernment
- MedlinePlus: Type 1 diabetesGovernment
Next: In children
Catching it before ketoacidosis
What happens
The symptoms are specific if you know them.
What the research shows
- New bedwetting in a previously dry child is a classic and frequently missed clue.
- Drinking far more than usual, getting up at night to drink or urinate, unexplained weight loss, tiredness and irritability are the core signs.
- Thrush or recurrent skin infections can accompany them.
- A substantial proportion of children are diagnosed only in ketoacidosis, and younger children are at highest risk of that.
- Vomiting, abdominal pain, rapid deep breathing, fruity-smelling breath, drowsiness or confusion mean emergency care immediately.
- A finger-prick glucose test takes seconds and is the appropriate response to these symptoms in any child.
Why it matters
Awareness campaigns built around the four classic signs have reduced ketoacidosis rates at diagnosis where they have run, which is as clear a case for public education as exists.
What's still uncertain
- How to reduce ketoacidosis at diagnosis in children.
- The best setting for first-line glucose testing of symptomatic children.
Read more
- MedlinePlus: Diabetes in children and teensGovernment
- CDC: Diabetic ketoacidosisGovernment
- NIDDK: Diabetes in children and teensGovernment
Next: What else is checked
The rest of the first weeks
What happens
Autoimmunity travels in groups.
What the research shows
- Thyroid function and thyroid antibodies, because autoimmune thyroid disease is substantially more common in type 1 and is usually symptomless at first.
- Coeliac disease screening, which is also more common in type 1 and can present only as poor growth or erratic glucose.
- Lipids and blood pressure, because cardiovascular risk is raised over the long term.
- Kidney function and urine albumin, usually starting after five years in those diagnosed in childhood or from diagnosis in adults.
- Vitamin B12 where there is pernicious anaemia risk, and vitamin D status.
- A baseline eye examination, with regular screening starting within a few years of diagnosis.
Why it matters
The associated autoimmune conditions are worth knowing about, because thyroid disease and coeliac disease both destabilise glucose control while remaining otherwise silent.
What's still uncertain
- The best screening intervals for associated autoimmunity.
- When to begin complication screening in childhood-onset disease.
Read more
- American Diabetes Association: standards of care resourcesNonprofit
- NIDDK: Type 1 diabetesGovernment
- MedlinePlus: Autoimmune diseasesGovernment